Table 1.
PAD | CON | |
---|---|---|
Number of subjects (men/women) | 11 (8/3) | 10 (7/3) |
Age (years) | 65 ± 2 | 65 ± 2 |
Height (m) | 1.69 ± 0.03 | 1.74 ± 0.03 |
Weight (kg) | 79 ± 4 | 78 ± 4 |
BMI (kg m−2) | 27.7 ± 1.2 | 25.8 ± 0.7 |
SBP (mmHg) | 137 ± 5 | 127 ± 5 |
DBP (mmHg) | 77 ± 2 | 77 ± 2 |
MAP (mmHg) | 94 ± 3 | 93 ± 3 |
HR (bpm) | 72 ± 3* | 59 ± 3 |
RBFV (cm sec−1) | 51.4 ± 6.2 | 55.1 ± 6.2 |
RVR (au) | 2.1 ± 0.2 | 1.9 ± 0.2 |
ABI (most affected leg) | 0.62 ± 0.06* | 1.04 ± 0.03 |
ABI (least affected leg) | 0.81 ± 0.05* | 1.13 ± 0.04 |
Note that data for all variables except RBFV and RVR are similar to data published in our previous study (see Subjects section in Methods; Muller et al. 2012). PAD, peripheral arterial disease; CON, controls; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure; HR, heart rate; RBFV, renal blood flow velocity; RVR, renal vascular resistance; ABI, ankle-brachial index.
Significantly different from CON (P < 0.05).